pyrazinamide has been researched along with Anemia, Aplastic in 2 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kerridge, I | 1 |
| Ethell, M | 1 |
| Potter, M | 1 |
| Prentice, HG | 1 |
| Whitcomb, ME | 1 |
| Rocklin, RE | 1 |
2 other studies available for pyrazinamide and Anemia, Aplastic
| Article | Year |
|---|---|
Mycobacterium tuberculosis infection following allogeneic peripheral blood stem cell transplantation.
Topics: Adult; Anemia, Aplastic; Antitubercular Agents; Drug Therapy, Combination; Humans; Immunocompromised | 2003 |
Transfer factor therapy in a patient with progressive primary tuberculosis.
Topics: Adult; Aminosalicylic Acids; Anemia, Aplastic; Cell Migration Inhibition; Ethambutol; Female; Humans | 1973 |